SBIO vs. MARB ETF Comparison

Comparison of ALPS Medical Breakthroughs ETF (SBIO) to First Trust Merger Arbitrage ETF (MARB)

SBIO

ALPS Medical Breakthroughs ETF

SBIO Description

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$34.45

Average Daily Volume

12,429

Number of Holdings ^*

* may have additional holdings in another (foreign) market

MARB

First Trust Merger Arbitrage ETF

MARB Description

The investment seeks to provide investors with capital appreciation. Under normal market conditions, the fund seeks to achieve its investment objective by establishing long and short positions in the equity securities of companies that are involved in a publicly-announced significant corporate event, such as a merger or acquisition. It's portfolio may include equity securities issued by U.S. and non-U.S. companies, including American Depositary Receipts (ADRs), and derivatives, including total return swaps. The fund may invest in securities issued by small, mid and large capitalization issuers. It is non-diversified.

Grade (RS Rating)

Last Trade

$19.60

Average Daily Volume

25,255

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	SBIO	MARB
30 Days	0.25%	-1.15%
60 Days	-8.48%	-0.75%
90 Days	2.87%	-0.70%
12 Months	10.14%	1.04%

1 Overlapping Holdings

	Symbol	Grade	Weight in SBIO	Weight in MARB	Overlap
	CERE	A	4.98%	3.05%	3.05%

SBIO Overweight 83 Positions Relative to MARB

Symbol	Grade	Weight
VKTX	C	5.12%
PCVX	D	4.5%
RVMD	A	4.16%
ALPN	A	2.73%
ALKS	F	2.57%
CRNX	A	2.35%
AXSM	C	2.27%
XENE	C	2.09%
SWTX	D	2.06%
IDYA	D	1.97%
IMCR	D	1.91%
SMMT	C	1.84%
ACLX	D	1.81%
ACAD	F	1.81%
MRUS	C	1.77%
CLDX	C	1.7%
CORT	D	1.67%
RYTM	C	1.59%
VERA	C	1.54%
DNLI	F	1.5%
VCEL	C	1.49%
NTLA	F	1.44%
ARVN	D	1.42%
GERN	B	1.39%
DCPH	A	1.32%
KROS	D	1.32%
RNA	A	1.31%
GLPG	F	1.26%
AGIO	A	1.25%
SNDX	D	1.2%
EWTX	B	1.15%
CPRX	D	1.14%
ZLAB	F	1.06%
INBX	D	1.04%
KURA	D	1.01%
DAWN	A	0.99%
PTGX	D	0.96%
MORF	F	0.93%
XNCR	C	0.93%
RCUS	F	0.9%
FDMT	D	0.85%
TARS	C	0.84%
IRWD	F	0.84%
VRNA	D	0.82%
VIR	C	0.8%
MIRM	D	0.77%
PRTA	F	0.76%
MNKD	D	0.76%
AKRO	F	0.72%
MDXG	D	0.71%
LQDA	D	0.63%
MGNX	D	0.61%
BCRX	F	0.6%
SPRY	C	0.59%
VRDN	F	0.59%
OPK	C	0.58%
ETNB	F	0.53%
ZNTL	F	0.51%
PLRX	F	0.51%
KNSA	C	0.5%
AUPH	F	0.48%
ARCT	F	0.46%
ANAB	B	0.45%
IRON	F	0.45%
SVRA	D	0.41%
AVTE	D	0.37%
OLMA	F	0.36%
MLYS	D	0.35%
CMPS	D	0.34%
ALEC	F	0.33%
ALLO	F	0.32%
FULC	D	0.31%
TVTX	F	0.3%
ITOS	C	0.27%
BMEA	F	0.27%
REPL	F	0.26%
AURA	D	0.25%
AVXL	F	0.2%
INZY	D	0.19%
ENTA	C	0.19%
RAPT	F	0.18%
VNDA	B	0.17%
RPHM	D	0.04%

SBIO Underweight 22 Positions Relative to MARB

Symbol	Grade	Weight
PXD	B	-5.82%
ACI	D	-4.96%
AMED	D	-4.57%
AXNX	C	-3.96%
ANSS	D	-3.6%
X	F	-3.53%
HES	B	-3.48%
JNPR	D	-3.3%
DFS	B	-3.26%
CTLT	C	-2.98%
VZIO	D	-2.93%
NS	D	-2.46%
LBAI	B	-2.39%
NWLI	A	-2.09%
SP	B	-1.53%
CPRI	F	-1.44%
SNPS	D	--2.02%
PFS	B	--2.45%
SUN	D	--2.47%
CVX	B	--3.65%
COF	B	--3.86%
XOM	B	--6.25%

SBIO: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Diagnostics & Research Drug Manufacturers - Major Medical Care Facilities Medical Devices